The Canadian stocks we’ve found have quietly seen impressive gains with an average return 414% year-to-date
SmallCapPower | November 26, 2019: On November 19, 2019, the TSX Composite Index hit an all-time high of 17,011.41 and is up ~17% year-to-date. While this is impressive, there have been some smaller cap stocks that have seen even bigger gains. Small cap stocks are typically overlooked by investors, seeing that most analysts don’t cover these companies, however some have quietly produced substantial returns for shareholders. Today we have identified four Canadian stocks that are not well known by investors yet have been stellar performers over the past year.
*Share price data as at November 22, 2019, data obtained from S&P Capital IQ
Blackrock Gold Corp. (TSXV:BRC) – $0.23
Metals and Mining
Blackrock is a junior gold-focused exploration company that is focused on development of mineral properties in North America. The Company’s flagship asset is the Silver Cloud property, a large, 4,537-hectare (11,210 acres) claim, which contains a low-sulphidation epithermal gold & silver project located along on the established Northern Nevada Rift gold trend in north-central Nevada. The site had historically produced gold with grades of 158g/tonne over 1.5m. On June 27, 2019, the Company announced that it had discovered a new east-west vein system at the Silver Cloud property, which could have high-grade gold deposits based on soil samples. The Company issued a press release on October 24, 2019, saying that it had begun a fully-financed 2000m drilling program at the Silver Cloud property.
- Market Cap: $13.7M
- 90-Day Return: -11.8%
- YTD-Return: +462.5%
- 90-Day Average Trading Volume: 237,590
Burcon NutraScience Corporation (TSX:BU) – $0.85
Chemicals
Burcon NutraScience is a Canada-based company engaged in development of functional and renewable plant proteins. The Company has developed a portfolio of composition, application, and process patents originating from a core protein extraction and purification technology. The Company and its subsidiary have developed CLARISOY, a soy protein; and are developing Peazazz, a pea protein, and Puratein, Supertein and Nutratein, approximately three canola protein isolates. The Company’s products are targeted towards the protein ingredient market and are particularly suited to health and wellness applications.
- Market Cap: $74.9M
- 90-Day Return: -37.0%
- YTD-Return: +400.0%
- 90-Day Average Trading Volume: 460,090
Amex Exploration Inc. (TSXV:AMX) – $1.10
Metals and Mining
Amex Exploration is a Canada-based mining exploration company focused on exploration activities conducted in Canada and Mexico. Its properties include the Perron Property, Normetal Property, Cameron Property, Lac Indicateur property, Eastmain Centre property, Eastmain North Property, Natora Property and Nueva Escondida property. The Company’s flagship asset, the Perron Property, consists of approximately 120 mining claims covering an area of over 4,510 hectares in northern Quebec. Amex’s summer drilling program found high-grade gold intersected on the Gratien gold zone at Perron, with results up to 16.48 g/t Au over 14.6 m, including 315.4 g/t Au over 0.5 m and 102.96 g/t Au over 0.7 m. On November 7, 2019, AMX announced a $8M bought deal with a strategic investment from Eric Sprott. Use of proceeds from the raise are for a fully-funded 100,000 m drilling program for 2019 and 2020 at the Perron property.
- Market Cap: $69.0M
- 90-Day Return: +22.2%
- YTD-Return: +423.8%
- 90-Day Average Trading Volume: 87,670
Sirona Biochem Corp. (TSXV:SBM) – $0.40
Biotechnology
Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary technology. The Company’s technology specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety in beauty products. Sirona’s compounds are licensed to leading beauty and cosmetics companies around the world in return for licensing fees, milestone fees and ongoing royalty payments. Sirona’s laboratory is in France and is the recipient of multiple French national scientific awards and European Union and French government grants. The Company has six product lines: SGLT2 Inhibitor, Skin Lightener I, GlycoProteMin-Anti aging, Anti-inflammatory, Anti-infective and Skin Lightener II. Sirona research and development is focused on three programs: 1) Therapeutics, which includes diabetes, anti-inflammatories and anti-infectives; 2) Cosmeceuticals, which includes anti-aging and depigmenting agents (skin lighteners); and 3) Biological ingredients, which includes inducers and adjuvants for biological development and preservation.
- Market Cap: $89.2M
- 90-Day Return: -14.0%
- YTD-Return: +370.6%
- 90-Day Average Trading Volume: 146,790
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
